Tonix Pharmaceuticals Holding (TNXP) Net Margin Growth (1y) (2023 - 2026)
Tonix Pharmaceuticals Holding (TNXP) Net Margin Growth (1y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,140.12 Bn | 66,139.83 Bn | - | - |
| 2 | Nanobiotix | 1,933.82 Bn | 1,933.76 Bn | - | - |
| 3 | Akari Therapeutics | 1,022.34 Bn | 1,022.34 Bn | - | - |
| 4 | BeOne Medicines | 472.04 Bn | 467.25 Bn | 1.35 Bn | 1,491.00 |
| 5 | Vertex Pharmaceuticals | 122.28 Bn | 115.03 Bn | 2.59 Bn | 1,120.00 |
| 6 | Regeneron Pharmaceuticals | 70.07 Bn | 61.31 Bn | 3.31 Bn | -653.00 |
| 7 | Belite Bio | 62.66 Bn | 62.66 Bn | - | - |
| 8 | Argenx Se | 56.16 Bn | 50.98 Bn | 1.41 Bn | 447.00 |
| 9 | Alnylam Pharmaceuticals | 37.56 Bn | 34.55 Bn | 959.66 Mn | 2,072.00 |
| 10 | Tonix Pharmaceuticals Holding | 141.73 Mn | 141.73 Mn | 5.30 Mn | 10,845.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10,845.00 |
| Dec 31, 2025 | -1,408.00 |
| Sep 30, 2025 | -46,930.00 |
| Jun 30, 2025 | 215,274.00 |
| Mar 31, 2025 | -9,094.00 |
| Dec 31, 2024 | -13,324.00 |
| Sep 30, 2024 | 19,765.00 |
| Jun 30, 2024 | -276,764.00 |
| Sep 30, 2023 | 9,597.00 |
| Jun 30, 2023 | -22,155.00 |